adults aged 18-75 years who undergo open thyroid lobectomy or total thyroidectomy through a conventional transverse Kocher incision Thyroidectomy Triamcinolone Acetonide Scar Hypertrophic scar Keloid
Conditions
Interventions
triamcinolone acetonide intradermal injection,no intervention
Experimental Drug,No Intervention No treatment
Triamcinolone acetonide group,Control group
Sponsors
Mahidol university
Eligibility
Sex/Gender
All
Age
18 Years to 75 Years
Inclusion criteria
Inclusion criteria: -Plan for open thyroidectomy (lobectomy/total) with Kocher incision -Able to come for follow up up to 6 months
Exclusion criteria
Exclusion criteria: -History of keloid/hypertrophic scar at any part of the body -Undergone open thyroidectomy (lobectomy/total) with Lateral neck incision -History of neck surgery or have scar across the neck area -Underlying diseases that interfere with healing process eg. uncontrolled diabetes mellitus, immunocompromised host, autoimmune disease -History of allergy to triamcinolone acetonide -Preoperatively or Intraoperatively have contaminated wound or active infection at neck area -Unable to follow up up to 6 months
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Patient's scar satisfication 6 months after operation Patient Scar Assessment Scale component of the Patient and Observer Scar Assessment Scale | — |
Secondary
| Measure | Time frame |
|---|---|
| Patient's scar satisfication 3 months after operation Patient Scar Assessment Scale component of the Patient and Observer Scar Assessment Scale,Assessor evaluation of patient's scar 3,6 months after operation Patient Scar Assessment Scale component of the Patient and Observer Scar Assessment Scale,Assessor evaluation of patient's scar 3,6 months Scar width will be measured in millimeters | — |
Countries
Thailand
Contacts
Public ContactRawisara Sritrakool
Department of Otolaryngology
Outcome results
None listed